Full Data
?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets
Join Now!
Need this critical market data?
Access thousands of market events, data points, and news articles!
Already have an account?
Login
Home » News » Southwest Securities gives Zuoli Pharmaceutical a buy rating: high-speed growth in 2022 is worth looking forward to with a target price of 11 yuan jqknews